BEIJING INSTITUTE FOR CANCER RESEARCH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
  
 
C07K PEPTIDES 2134
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0049,802 CONTROLLED MULTI-NEEDLE POINT EXPANDING RADIOFREQUENCY ABLATION ELECTRODE NEEDLEAug 21, 17Feb 22, 18[A61B]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9637797 Methods and nucleotide fragments of predicting occurrence, metastasis of cancers and patients' postoperative survival in vitroFeb 13, 12May 02, 17[C07H, C12Q, C12P, G06F]
9416423 Primer group for detecting CPG island methylation of P16 gene using methylation-specific fluorescence techniqueJan 01, 11Aug 16, 16[C12Q]
7250395 Antagonist peptides to VEGF receptor Flt-1Sep 12, 01Jul 31, 07[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2006/0252,043 Method for in vitro detection aberrant dysplasia, and the artificial nucleotides being usedAbandonedMar 13, 03Nov 09, 06[C07H, C12Q]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.